This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Regular Glucose Monitoring Increases Medication Adherence and Reduces A1c

Posted: Sunday, October 28, 2012

Blood glucose monitoring at least once a day is associated with reduced A1C levels and greater adherence to medication in type 2 diabetes patients who do not take insulin.

The Four Main Risk Factors for PAD

Posted: Sunday, October 28, 2012

Four risk factors for peripheral arterial disease (PAD) account for the vast majority of cases.

Diabetes with Psoriasis Increases Vascular Risk

Posted: Tuesday, October 23, 2012

Patients with diabetes and psoriasis are significantly more likely to develop new-onset, diabetes-related microvascular and macrovascular complications than are psoriasis-free patients with diabetes.

Sleepless Nights Increase Risk for Diabetes

Posted: Tuesday, October 23, 2012

Sleep deprivation can affect insulin resistance.

Foot Ulceration for Diabetes Patients Doubles Mortality Risk

Posted: Monday, October 22, 2012

Diabetic foot ulceration was associated with a nearly 2-fold increased risk for all-cause mortality above that of diabetes alone, according to a meta-analysis of 8 studies.

Sitting for Too Long Doubles Diabetes Risk

Posted: Sunday, October 21, 2012

The more time people spend sitting, the greater their risk of diabetes, cardiovascular events, and death.

EASD: Increasing Physical Activity Slashes CV Events, Deaths by 66% for Type 2's

Posted: Tuesday, October 09, 2012

Higher levels of leisure-time physical activity cut the risk of cardiovascular and all-cause mortality in people with type 2 diabetes.

EASD: New EASD/ADA Position Paper Shifts Treatment Goals with 7 Key Points

Posted: Tuesday, October 09, 2012

A new position statement for treatment of type 2 diabetes treatment focuses on the individual patient rather than a "one number fits all" HbA1c target.

EASD: Once a Year Exenatide Introduced at EASD

Posted: Monday, October 08, 2012

Continuous long-term delivery of exenatide with Intarcia's osmotic mini-pump system allows optimal dose selection for improved glycemic control, ensures adherence, and improves patient tolerability.

EASD: Merck's Investigational Once-Weekly DPP-4 Inhibitor Significantly Lowered Blood Sugar in Patients with Type 2 Diabetes

Posted: Monday, October 08, 2012

Merck announced Phase IIb data for MK-3102, the company's investigational once-weekly DPP-4 inhibitor in development for the treatment of type 2 diabetes.